CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Lab Expectations listing page

Read More →

Targeting B-Cell Maturation Antigen (BCMA) Holds Promise for Multiple Myeloma Cure

Multiple myeloma (MM) is a type of hematopoietic malignancy characterized, in part, by bone pain, an...
Amrik Singh, PhD Aug 8, 2018

GPNMB: A Promising Immunotherapeutic Target for Triple Negative Breast Cancer

The last few years have witnessed several breakthroughs in the immuno-oncology space. Treatments tha...
Amrik Singh, PhD Apr 4, 2018

Immunotherapy: Empowering Nature’s Anti-Tumor Artillery - Part I

Immunotherapy as an anti-neoplastic strategy has gradually claimed the spotlight over the past sever...
Liana G Dec 6, 2017

Webinar | Validation of a Glycosylation-Independent Antibody Against the Cancer Stem Cell Marker CD133

WEBINAR: Validation of a Glycosylation-Independent Antibody Against the Cancer Stem Cell Marker CD13...
Chris Sumner Nov 22, 2017

In-depth Characterization of Immune Checkpoints in the Tumor Microenvironment

Characterize Immune Checkpoint Proteins & T Cell Exhaustion Using Multiplex IHC Advances in immu...
Chris Sumner May 3, 2017

Webinar | Key Signaling Pathways in Cancer: Emerging Trends in Immunometabolism

Immune cells divide rapidly when mounting an immune response against a pathogen, for example, or whe...
Carolyn P Mar 22, 2017

POSTER | Tumor Immunology: Examining the Microenvironment

The immune system is tasked with distinguishing ‘self’ from ‘non-self’. Tumors can, quite often, be ...
Liana G Oct 21, 2015

Immunotherapy: Empowering Nature’s Anti-tumor Artillery - Part II

At your last visit we talked about the rapidly rising popularity of cancer immunotherapy and how it ...
Liana G Sep 9, 2015

      Categories

      CST Newsletter

      Popular Posts

      Recent Posts
      blog-footer-landscape-blue-gradient